Navigation Links
Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
Date:10/17/2007

p=0.012 for per protocol populations). While in this exploratory study this endpoint was identified as a secondary end point, FDA currently requires the absolute change (rather than percent change) in the number of inflammatory lesions as one of the co-primary endpoints, along with Treatment Success, for demonstrating efficacy in a Phase III trial in rosacea.

"Based on these encouraging results, we have selected once-daily Omiganan 2.5% for further study in rosacea, which is a critical step towards potential commercialization, either directly or in collaboration with a partner," commented Robert J. Bitterman, President and CEO of Cutanea.

About Rosacea

Rosacea is a chronic dermatologic disorder with no current cure and a poorly understood etiology that afflicts an estimated 14 million Americans. Symptoms primarily manifest on the facial skin and include facial flushing, central facial inflammatory lesions, and facial erythema. According to surveys conducted by the National Rosacea Society (NRS), nearly 70% of rosacea patients said the disorder had lowered their self-confidence and self-esteem; 41% reported it had caused them to avoid public contact or cancel social engagements; and nearly 30% claimed to have missed work due to rosacea. Of these rosacea patients surveyed by the NRS that sought medical treatment, over 70 percent reported an improvement in their emotional and social well-being.

Typical onset of rosacea occurs between 30 and 50 years of age and is more prevalent in women than men. Clearing up the initial outbreak is only the beginning, as rosacea is characterized by periods of relapses and remissions. Relapse episodes can be spurred by sun exposure, stress, hot or cold weather, alcohol, spicy foods, exercise, and certain skin care products and medications.

Absent a cure for rosacea, treatment is aimed at alleviating the disorder's symptoms. Topical or oral medications are generally prescribed for mild to moderate papulopus
'/>"/>

SOURCE Cutanea Life Sciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Optimer Pharmaceuticals, Inc. (Nasdaq: ... the 28th Annual J.P. Morgan Healthcare Conference at ... on Wednesday, January 13, 2010. Michael N. Chang, ... at 2:30 p.m. Pacific Time (5:30 p.m. Eastern ... live audio webcast of this presentation will be ...
(Date:12/16/2009)... CHICAGO, Dec. 16 Advanced Life Sciences ... positive top-line results from a pivotal, non-human primate ... (cethromycin) against an inhaled lethal dose of tularemia. ... survival rate at the doses tested. All ... received 16 mg/kg once-a-day of Restanza (approximate to ...
(Date:12/15/2009)... 15 Warner Chilcott plc (Nasdaq: ... Chilcott Corporation (the "Company") has commenced a cash ... the conditions set forth in the Company,s Offer ... 15, 2009 (the "Offer to Purchase"), for any ... notes due 2015 (the "Notes"). ,, The Company ...
Breaking Medicine Technology:Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 1Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 2Repligen to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference Wednesday September 9th 2 3A25 p m EDT 13791 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 1Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 2Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 3Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 4Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara 28R 29 for Treatment of Brain Ca 4935 5September 2009 is Atrial Fibrillation Month 55975 1September 2009 is Atrial Fibrillation Month 55975 2
(Date:12/16/2009)... Cards have announced a great addition to one of the ... navigate website at www.hallmark.co.uk/specialoccasions , customers can now personalise just ... and photos and then order as many copies of their design ... ... (PRWEB) December 16, 2009 -- Just in time for the Christmas ...
(Date:12/16/2009)... be the perfect gift to give that special woman who has ... Licensed Esthetician Mary Schook introduces exceptional beauty products online while educating ... , ... (PRWEB) December 16, 2009 -- The holidays are ... that special woman who has everything? Why stem cells, of course!, ...
(Date:12/16/2009)... loved ones this holiday season, give them the gift of time ... care, and pet care through Delegate Source. , ... ... and Boulder metro areas have the opportunity to give a unique ... Delegate Source,s " Give a Gift " program to provide household ...
(Date:12/15/2009)... 15 The failure of the U.S. ... cut costs, much less the more effective direct ... latest example of how big industry controls the ... proposed drug amendment by Senator Dorgan (D-ND) was ... campaign pledge to allow Medicare to directly negotiate ...
(Date:12/15/2009)... Calls For Preserving State Authority, Ban on Annual ... WASHINGTON, Dec. 15 Consumer Watchdog condemned ... those over 55 and the public option from ... group said that the Senate must still make ... to prevent ceding the entire health care system ...
Breaking Medicine News(10 mins):Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5
... and doctors need to communicate that more, study suggests , , ... patients who die in the intensive care units of hospitals ... process doctors refer to as "stuttering," a new study found. ... such a process, doctors feel this was frequently not in ...
... Consumer-friendly Nutrition Information Part of Larger Health and,Nutrition ... Incorporated today,announced it is proud to be the ... Guideline Daily Amount (GDA) nutrition labeling on,all of ... packages will be redesigned to feature new graphics ...
... Volunteers Mount Winning Effort to Fight Skin Cancer, at LPGA,s ... ... Triumphs, HALF MOON BAY, Calif., Oct. 17 Volunteer,dermatologists, nurses, medical ... recent LPGA,s Samsung,World Championship in Half Moon Bay, CA to combat skin ...
... GBH to offer the Industry,s First Available Standards-Based 1080p30, 720p60 ... , ... Los Angeles, CA (PRWEB) ... audio and video conferencing solutions, today announced the next generation ...
... Innovative Health Website Helps Reach Health-Conscious Consumers, ... and 70 million,Americans experience some sort of digestive ... that Americans haven,t "digested" the ways in,which prebiotics ... Inc. is helping to raise awareness for prebiotics ...
... incomes are particularly challenged by rising expenses, including housing, healthcare and ... ... Ill. (Vocus) October 16, 2008 -- For the more than 8.5 ... a decision on their application for benefits, the 5.8 percent cost ...
Other Medicine News:Health News:Delicate Debate Urged Over Withdrawal of Life Support 2Health News:Delicate Debate Urged Over Withdrawal of Life Support 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 2Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 4Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 5Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 2Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 3Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 4Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 2Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 3Health News:MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 3Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 4Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 5Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 6Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: